Gastroenterology
From the Journals
Could intermittent fasting improve GERD symptoms?
“If a patient is willing to do intermittent fasting, and certainly if they have other reasons [for doing so], I think it doesn’t hurt, and it...
Conference Coverage
Midodrine may be comparable to albumin for PICD prevention in ACLF
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...
Conference Coverage
Bepirovirsen: Is a ‘functional cure’ for HBV on the horizon?
“Bepirovirsen is just one RNA-based HBV therapy now being pursued. Several other antisense RNAs as well as the more malleable small interfering...
From the Journals
Celiac disease linked to higher risk for rheumatoid arthritis, juvenile idiopathic arthritis
“I hope that our study can ultimately change clinical practice by lowering the threshold to evaluate celiac disease patients for inflammatory...
Feature
Doctors urge screening for autoimmune disorders for patients with celiac disease
At least in some cases, people with one autoimmune disorder should be tested for others, celiac disease specialists say.
Conference Coverage
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
From the Journals
Pediatric celiac disease incidence varies across U.S., Europe
“From a policy standpoint, this informs future screening practices and supports efforts toward mass screening, at least in some areas.”
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
Latest News
Many moms don’t remember well-child nutrition advice
Less than 50% recalled recommendations to limit meals in front of TV and not to force a child to finish meals.
From the Journals
Novel drug eases Parkinson’s-related constipation in early trial
The drug, ENT-01, targets abnormal clumps of alpha-synuclein that are a hallmark of Parkinson’s disease.
Conference Coverage
Noninvasive tests may provide prognostic value in NAFLD
Fibrosis biomarkers were significantly predictive of event-free survival probability.